Alzheimer's disease is the most widely recognized manifestation of dementia. There is no cure for the sickness, which compounds as it advances, and inevitably prompts demise.
Journal of Molecular and genetic medicine is an international multidisciplinary journal to encourage advance in understanding the etiology, pathogenesis, and the study of disease transmission, heredity, conduct, and medicine and brain research of Alzheimer's disease. The journal distributes research reports, reviews, short communications, hypotheses, book reviews, and letters-to-the-editor. . The journal is committed to giving an open gathering to unique research that will assist our major understanding of Alzheimer's disease.
Journal of Molecular and Genetic medicine intends to impart the enhanced clinical profits for human wellbeing from the trial and translational exploration performed utilizing molecular tools. Areas that are secured incorporate, yet are not restricted to, tumor science, immunology, neuroscience, cardiovascular disease, heredity and genomics, gene therapy and stem cells and regenerative medicine.
OMICS Group Journals encourages original and well researched articles for publication. With the help of a strong 25, 000 experts as editorial board members and reviewers, OMICS Group journals uphold the standard review process. We have more than 50,000+ editorial board members and more than 15 million readers. . It has more than 700+ peer-reviewed journals and organizes more than 3000+ International Scientific Conferences.
Last date updated on June, 2014